机构

• 上海药物研究所 [9]
• 合肥物质科学研究院 [2]
• 力学研究所 [1]
• 地理科学与资源研究所 [1]
• 化学研究所 [1]
• 过程工程研究所 [1]
• 更多

采集方式

• OAI收割 [17]
• iSwitch采集 [1]

内容类型

• 期刊论文 [18]

发表日期

• 2025 [1]
• 2024 [3]
• 2022 [3]
• 2020 [2]
• 2019 [1]
• 2018 [1]
• 更多

学科主题

• Pharmacolo... [1]

筛选

浏览/检索结果: 共18条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Development of a bispecific antibody-drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors 期刊论文  OAI收割 EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 卷号: 14, 期号: 1, 页码: 16 作者:  Luo, Meiying;  Wang, Xiaohuan;  Yu, Guoji;  Ji, Jing;  Li, Long   |  收藏  |  浏览/下载：13/0  |  提交时间：2025/04/07 EpCAM  CLDN3  Antibody-drug conjugate  Dxd  Solid tumor   CAR-macrophage: Breaking new ground in cellular immunotherapy 期刊论文  OAI收割 FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 卷号: 12, 页码: 12 作者:  Huang, Ting;  Bei, Chenqi;  Hu, Zhenhua;  Li, Yuanyuan   |  收藏  |  浏览/下载：5/0  |  提交时间：2024/11/26 macrophage  chimeric antigen receptor  CAR-M therapy  tumor immunotherapy  solid tumor   Proteomics analysis of histone deacetylase inhibitor-resistant solid tumors reveals resistant signatures and potential drug combinations 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 11 作者:  Hao, Bing-bing;  Ma, Ke;  Xu, Jun-yu;  Fan, Ru-feng;  Zhao, Wen-si   |  收藏  |  浏览/下载：32/0  |  提交时间：2024/03/25 solid tumor  histone deacetylase inhibitor  vorinostat (SAHA)  drug resistance  proteomics   The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：57/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文  OAI收割 BMC Medicine, 2022, 卷号: 20, 期号: 1 作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun   |  收藏  |  浏览/下载：34/0  |  提交时间：2022/11/21 Tucidinostat  Tumor microenvironment  PD-L1  CCL5  Solid tumor   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文  OAI收割 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo   |  收藏  |  浏览/下载：63/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   Modeling the efficacy of different anti-angiogenic drugs on treatment of solid tumors using 3D computational modeling and machine learning 期刊论文  OAI收割 COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 卷号: 146, 页码: 16 作者:  Mousavi, Milad;  Manshadi, Mahsa Dehghan;  Soltani, Madjid;  Kashkooli, Farshad M.;  Rahmim, Arman   |  收藏  |  浏览/下载：40/0  |  提交时间：2022/09/21 Solid tumor  Tumor growth  Anti-angiogenic drugs  Bevacizumab  Ranibizumab  Brolucizumab  Artificial intelligence  Cancer   Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy 期刊论文  OAI收割 FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 卷号: 8, 页码: 8 作者:  Tu, Bin;  Zhang, Meng;  Liu, Tuanbing;  Huang, Yongzhuo   |  收藏  |  浏览/下载：19/0  |  提交时间：2020/12/24 Histone deacetylase inhibitors (HDACi)  nanotechnology  nanomedicine  cancer therapy  solid tumor  targeting drug delivery  combination therapy   Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors 期刊论文  OAI收割 CHINESE JOURNAL OF CANCER RESEARCH, 2020, 卷号: 32, 期号: 3, 页码: 370-+ 作者:  Li, Huiping;  Liu, Rongrui;  Shao, Bin;  Ran, Ran;  Song, Guohong   |  收藏  |  浏览/下载：47/0  |  提交时间：2020/12/24 Phase I  PARP inhibitor (fluzoparib)  solid tumor  pharmacokinetics  safety  antitumor activity   Magnetic Nanoclusters Armed with Responsive PD-1 Antibody Synergistically Improved Adoptive T-Cell Therapy for Solid Tumors 期刊论文  OAI收割 ACS NANO, 2019, 卷号: 13, 期号: 2, 页码: 1469-1478 作者:  Nie, Weidong;  Wei, Wei;  Zuo, Liping;  Lv, Chengliang;  Zhang, Fan   |  收藏  |  浏览/下载：70/0  |  提交时间：2019/06/14 Adoptive T-cell Therapy  Intratumoral Microenvironment  Magnetic Nanoclusters  Ph Sensitive  Solid Tumor